Thermo Total Assets vs Accounts Payable Analysis
TMO Stock | USD 577.39 2.80 0.49% |
Thermo Fisher financial indicator trend analysis is much more than just breaking down Thermo Fisher Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Thermo Fisher Scientific is a good investment. Please check the relationship between Thermo Fisher Total Assets and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Total Assets vs Accounts Payable
Total Assets vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Thermo Fisher Scientific Total Assets account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Thermo Fisher's Total Assets and Accounts Payable is 0.98. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Thermo Fisher Scientific, assuming nothing else is changed. The correlation between historical values of Thermo Fisher's Total Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Thermo Fisher Scientific are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Assets i.e., Thermo Fisher's Total Assets and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Assets
Total assets refers to the total amount of Thermo Fisher assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Thermo Fisher Scientific books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Accounts Payable
An accounting item on the balance sheet that represents Thermo Fisher obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Thermo Fisher Scientific are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Thermo Fisher's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Thermo Fisher Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Thermo Fisher's Selling General Administrative is very stable compared to the past year. As of the 25th of April 2024, Tax Provision is likely to grow to about 469.3 M, while Discontinued Operations is likely to drop (3.6 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 39.2B | 44.9B | 42.9B | 45.0B | Depreciation And Amortization | 2.1B | 3.7B | 3.4B | 3.6B |
Thermo Fisher fundamental ratios Correlations
Click cells to compare fundamentals
Thermo Fisher Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thermo Fisher fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 58.4B | 69.1B | 95.1B | 97.2B | 98.7B | 103.7B | |
Short Long Term Debt Total | 17.8B | 21.7B | 34.9B | 34.5B | 34.9B | 36.7B | |
Other Current Liab | 2.7B | 4.2B | 5.4B | 5.4B | 4.8B | 5.1B | |
Total Current Liabilities | 6.2B | 10.3B | 13.4B | 17.0B | 14.0B | 14.7B | |
Total Stockholder Equity | 29.7B | 34.5B | 40.8B | 44.0B | 46.7B | 49.1B | |
Property Plant And Equipment Net | 5.4B | 6.7B | 9.9B | 10.9B | 9.4B | 9.9B | |
Net Debt | 15.4B | 11.4B | 30.4B | 26.0B | 26.8B | 28.2B | |
Retained Earnings | 22.1B | 28.1B | 35.4B | 41.9B | 47.4B | 49.7B | |
Cash | 2.4B | 10.3B | 4.5B | 8.5B | 8.1B | 8.5B | |
Non Current Assets Total | 45.2B | 45.5B | 72.0B | 69.7B | 74.1B | 77.8B | |
Non Currrent Assets Other | 1.9B | 2.5B | 4.4B | (2.8B) | 4.0B | 4.2B | |
Cash And Short Term Investments | 2.4B | 10.3B | 4.5B | 8.5B | 8.1B | 8.5B | |
Net Receivables | 5.0B | 6.5B | 8.9B | 9.4B | 8.2B | 8.6B | |
Common Stock Shares Outstanding | 403M | 399M | 397M | 394M | 388M | 272.7M | |
Liabilities And Stockholders Equity | 58.4B | 69.1B | 95.1B | 97.2B | 98.7B | 103.7B | |
Non Current Liabilities Total | 17.1B | 19.1B | 32.1B | 28.8B | 37.9B | 39.8B | |
Inventory | 3.4B | 4.0B | 5.1B | 5.6B | 5.1B | 5.3B | |
Other Current Assets | 1.2B | 1.1B | 1.6B | 1.6B | 3.2B | 3.4B | |
Other Stockholder Equity | 7.1B | 6.0B | 4.9B | 1.6B | 2.1B | 2.0B | |
Total Liab | 28.7B | 34.5B | 54.1B | 53.0B | 51.9B | 54.5B | |
Total Current Assets | 11.9B | 22.0B | 20.1B | 25.2B | 24.6B | 25.8B | |
Short Term Debt | 676M | 2.6B | 2.5B | 5.6B | 3.6B | 3.8B | |
Intangible Assets | 14.0B | 12.7B | 20.1B | 17.5B | 16.7B | 17.5B | |
Accounts Payable | 1.9B | 2.2B | 2.9B | 3.4B | 2.9B | 3.0B | |
Property Plant And Equipment Gross | 4.7B | 5.9B | 12.6B | 14.3B | 15.5B | 16.3B | |
Accumulated Other Comprehensive Income | (2.7B) | (2.8B) | (2.3B) | (3.1B) | (3.2B) | (3.1B) | |
Current Deferred Revenue | 916M | 1.3B | 2.7B | 2.6B | 2.7B | 2.8B | |
Good Will | 25.7B | 26.0B | 41.9B | 41.2B | 44.0B | 46.2B | |
Common Stock Total Equity | 434M | 437M | 439M | 441M | 507.2M | 352.8M | |
Short Term Investments | 26M | 31M | 37M | 28M | 1.8M | 1.7M | |
Common Stock | 434M | 437M | 439M | 441M | 442M | 357.4M | |
Other Liab | 4.8B | 5.1B | 8.1B | 5.7B | 6.5B | 6.9B | |
Other Assets | 1.2B | 1.6B | 3.0B | 2.2B | 2.6B | 2.7B | |
Long Term Debt | 17.1B | 19.1B | 32.3B | 28.9B | 31.3B | 32.9B | |
Treasury Stock | (3.7B) | (5.2B) | (6.8B) | (8.9B) | (8.0B) | (7.6B) | |
Property Plant Equipment | 4.7B | 5.9B | 8.3B | 9.3B | 10.7B | 11.2B | |
Net Tangible Assets | (10.1B) | (4.2B) | (21.2B) | (14.5B) | (13.1B) | (13.7B) | |
Retained Earnings Total Equity | 22.1B | 28.1B | 35.4B | 41.9B | 48.2B | 50.6B |
Currently Active Assets on Macroaxis
When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Thermo Stock analysis
When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.054 | Dividend Share 1.4 | Earnings Share 15.46 | Revenue Per Share 111.028 | Quarterly Revenue Growth (0.05) |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.